ALUMIS INC. ALMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-06-28
Chart by TradingView
1/9
Piotroski F — financial health
-7.78
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $24.1M | — | — |
| Operating income | -$453.8M | -$300.8M | -$158.2M |
| Net income | -$243.3M | -$294.2M | -$155.0M |
| Operating cash flow | -$369.5M | -$255.1M | -$130.0M |
| Free cash flow | -$370.2M | -$256.8M | -$134.5M |
| Total assets | $411.9M | $341.0M | $89.6M |
| Total liabilities | $110.6M | $80.9M | $53.5M |
| Shareholders' equity | $301.3M | $260.1M | -$339.3M |
| Ratios | |||
| Operating margin | -1886.9% | — | — |
| Net margin | -1011.7% | — | — |
| FCF margin | -1539.2% | — | — |
| Return on assets | -59.1% | -86.3% | -173.0% |
| Return on equity | -80.8% | -113.1% | 45.7% |
| Current ratio | 4.34 | 6.01 | 2.56 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 382,585 | $8.4M |
| RENAISSANCE TECHNOLOGIES LLC | 75,167 | $1.7M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -7.78 (distress)
- Working capital / assets 0.595
- Retained earnings / assets -2.189
- EBIT / assets -1.102
- Equity / liabilities 2.723
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001847367 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.